share_log

Canaccord Genuity Maintains Buy on Inari Medical, Maintains $75 Price Target

Canaccord Genuity Maintains Buy on Inari Medical, Maintains $75 Price Target

Canaccord Genuity维持对Inari Medical的买入,维持75美元的目标股价
Benzinga ·  04/12 12:00

Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and maintains $75 price target.

Canaccord Genuity分析师威廉·普洛瓦尼奇维持伊纳里医疗(纳斯达克股票代码:NARI)的买入并维持75美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发